Israel - English - Ministry of Health

remedix care ltd - glycine; l- alanine; l- aspartic acid; l- cysteine; l- glutamic acid; l- isoleucine; l- leucine; l- lysine; l- methionine; l- ornithine hydrochloride; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; taurine - solution for infusion - l- valine 0.76 g / 100 ml; l- tyrosine 0.045 g / 100 ml; l- tryptophan 0.2 g / 100 ml; l- threonine 0.37 g / 100 ml; taurine 0.06 g / 100 ml; l- serine 0.4 g / 100 ml; l- proline 0.3 g / 100 ml; l- phenylalanine 0.42 g / 100 ml; l- ornithine hydrochloride 0.318 g / 100 ml; l- methionine 0.24 g / 100 ml; l- lysine 1.1 g / 100 ml; l- leucine 1.0 g / 100 ml; l- isoleucine 0.67 g / 100 ml; l-histidine 0.38 g / 100 ml; glycine 0.4 g / 100 ml; l- glutamic acid 1.0 g / 100 ml; l- cysteine 0.189 g / 100 ml; l- aspartic acid 0.6 g / 100 ml; l-arginine 0.84 g / 100 ml; l- alanine 0.8 g / 100 ml - lysine - lysine - primene 10 % is indicated in 1) children and infants 2) neonates at term or premature of normal or low birth weight when oral or enteral nutrition is impossible insufficient or contraindicated.משטר מינון: 3/7/2019 שינוי בפרק 4.2 בעלון ללא שינוי ברשיון הנמוקים לבקשה: בהתאם לעלון רפרנס spc-uk ו-clinical overview

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - threonine, quantity: 3.7 mg/ml; proline, quantity: 3 mg/ml; glycine, quantity: 4 mg/ml; arginine, quantity: 8.4 mg/ml; tyrosine, quantity: 0.45 mg/ml; valine, quantity: 7.6 mg/ml; leucine, quantity: 10 mg/ml; serine, quantity: 4 mg/ml; isoleucine, quantity: 6.7 mg/ml; cysteine, quantity: 1.89 mg/ml; taurine, quantity: 0.6 mg/ml; lysine, quantity: 11 mg/ml; ornithine monohydrochloride, quantity: 3.18 mg/ml; histidine, quantity: 3.8 mg/ml; alanine, quantity: 8 mg/ml; aspartic acid, quantity: 6 mg/ml; methionine, quantity: 2.4 mg/ml; glutamic acid, quantity: 10 mg/ml; tryptophan, quantity: 2 mg/ml; phenylalanine, quantity: 4.2 mg/ml - injection, intravenous infusion - excipient ingredients: malic acid; water for injections - primene 10% amino acid iv infusion is indicated in infants and neonates at term or premature, for short-term use, of normal or low birth-weight when oral or enteral nutrition is impossible, insufficient or contraindicated. it is used as an amino acid component in a composite admixture of total parenteral nutrition.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - alanine, quantity: 16 g/l; glycylglutamine monohydrate, quantity: 30.27 g/l (equivalent: glutamine, qty 20 g); histidine, quantity: 6.8 g/l; methionine, quantity: 5.6 g/l; tryptophan, quantity: 1.9 g/l; threonine, quantity: 5.6 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: glycine, qty 10.27 g; equivalent: lysine, qty 9 g); valine, quantity: 7.3 g/l; arginine, quantity: 11.3 g/l; glycyltyrosine dihydrate, quantity: 3.45 g/l (equivalent: tyrosine, qty 2.28 g; equivalent: glycine, qty 0.94 g); serine, quantity: 4.5 g/l; proline, quantity: 6.8 g/l; glutamic acid, quantity: 5.6 g/l; leucine, quantity: 7.9 g/l; isoleucine, quantity: 5.6 g/l; aspartic acid, quantity: 3.4 g/l; phenylalanine, quantity: 5.85 g/l - injection, intravenous infusion - excipient ingredients: water for injections; citric acid - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate or severe catabolic status.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - valine; cysteine; arginine; threonine; tyrosine; methionine; alanine; proline; glycine; serine; glutamic acid; taurine; histidine; isoleucine; tryptophan; leucine; phenylalanine; lysine - solution for infusion - 500 millilitre(s) - solutions for parenteral nutrition; amino acids

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - proline, quantity: 6.8 g/l; isoleucine, quantity: 5.6 g/l; methionine, quantity: 5.6 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g; equivalent: glycine, qty 10.27 g); serine, quantity: 4.5 g/l; glycylglutamine monohydrate, quantity: 30.27 g/l (equivalent: glycine, qty 10.27 g; equivalent: glutamine, qty 20 g); alanine, quantity: 16 g/l; histidine, quantity: 6.8 g/l; glutamic acid, quantity: 5.6 g/l; tryptophan, quantity: 1.9 g/l; leucine, quantity: 7.9 g/l; valine, quantity: 7.3 g/l; aspartic acid, quantity: 3.4 g/l; phenylalanine, quantity: 5.85 g/l; glycyltyrosine dihydrate, quantity: 3.45 g/l (equivalent: tyrosine, qty 2.28 g; equivalent: glycine, qty 0.94 g); arginine, quantity: 11.3 g/l; threonine, quantity: 5.6 g/l - injection, intravenous infusion - excipient ingredients: citric acid; water for injections - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate or severe catabolic status.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - glycyltyrosine dihydrate, quantity: 3.45 g/l (equivalent: tyrosine, qty 2.28 g; equivalent: glycine, qty 0.94 g); histidine, quantity: 6.8 g/l; alanine, quantity: 16 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g; equivalent: glycine, qty 10.27 g); glycylglutamine monohydrate, quantity: 30.27 g/l (equivalent: glutamine, qty 20 g; equivalent: glycine, qty 10.27 g); glutamic acid, quantity: 5.6 g/l; phenylalanine, quantity: 5.85 g/l; valine, quantity: 7.3 g/l; leucine, quantity: 7.9 g/l; tryptophan, quantity: 1.9 g/l; methionine, quantity: 5.6 g/l; isoleucine, quantity: 5.6 g/l; serine, quantity: 4.5 g/l; proline, quantity: 6.8 g/l; arginine, quantity: 11.3 g/l; threonine, quantity: 5.6 g/l; aspartic acid, quantity: 3.4 g/l - injection, intravenous infusion - excipient ingredients: citric acid; water for injections - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate or severe catabolic status.

Philippines - English - FDA (Food And Drug Administration)

jireh agrichemical, inc.; distributor: jireh agrichemical, inc. - multivitamins , minerals , amino acids (vet.) - oral solution - formulation: each 1 l contains: retinol (vitamin a) - 2,500,000 iu cholecalciferol (vitamin d3) - 500,000 iu tocopherol (vitamin e) - 5,000 mg ascorbic acid (vitamin c) - 3,000 mg riboflavin (vitamin b2) - 2,000 mg pyridoxine (vitamin b6) - 2,000 mg thiamine (vitamin b1) - 1,000 mg menadione (vitamin k3) - 1,000 mg cyanocobalamin (vitamin b12) - 10 mg biotin (vitamin b7) - 2 mg propionic acid - 3,000 mg sodium (as chloride) - 5,000 mg magnesium (as sulphate) 1,500 mg potassium - 1,000 mg manganese (as sulphate) - 600 mg zinc (as sulphate) - 600 mg ferrous sulphate (iron) - 20 mg lysine - 5,000 mg glutamic acid - 3,500 mg glycine - mg threonine - 3,000 mg methionine - 1,500 mg arginine - 1,000 mg phenylalanine - 900 mg proline - 900 mg serine - 900 mg valine - 800 mg alanine - 750 mg tyrosine - 650 mg tryptophan - 600 mg histidine - 525 mg isoleucine - 500 mg cystine - 200 mg m d7)

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 8 g/l;  ;  ;  ; arginine 8.4 g/l;  ;  ;  ; aspartic acid 6 g/l;  ;  ; cysteine 1.89 g/l;  ; glutamic acid 10 g/l;  ; glycine 4 g/l;  ;  ; histidine 3.8 g/l;  ;  ; isoleucine 6.7 g/l;  ;  ;  ;  ;  ; leucine 10 g/l;  ;  ;  ;  ; lysine 11 g/l; methionine 2.4 g/l;  ;  ; ornithine hydrochloride 3.18 g/l;  ; phenylalanine 4.2 g/l;  ;  ;  ;  ; proline 3 g/l;  ;  ; serine 4 g/l;  ;  ; taurine 0.6 g/l;  ; threonine 3.7 g/l;  ;  ;  ; tryptophan 2 g/l;  ;  ;  ; tyrosine 0.45 g/l;  ;  ; valine 7.6 g/l;  ;   - solution for infusion - 10 % - active: alanine 8 g/l       arginine 8.4 g/l       aspartic acid 6 g/l     cysteine 1.89 g/l   glutamic acid 10 g/l   glycine 4 g/l     histidine 3.8 g/l     isoleucine 6.7 g/l           leucine 10 g/l         lysine 11 g/l methionine 2.4 g/l     ornithine hydrochloride 3.18 g/l   phenylalanine 4.2 g/l         proline 3 g/l     serine 4 g/l     taurine 0.6 g/l   threonine 3.7 g/l       tryptophan 2 g/l       tyrosine 0.45 g/l     valine 7.6 g/l     excipient: malic acid water for injection - primene 10% amino acids iv infusion solution is indicated in infants and neonates at term or premature for short-term use, of normal or low birth-weight when oral or enteral nutrition is impossible, insufficient or contraindicated. it is used as an amino acid component in a composite admixture of total parenteral solution.

Malta - English - Medicines Authority

fresenius kabi limited - phenylalanine; arginine; aspartic acid; alanine; threonine; valine; glutamic acid; glycine; isoleucine; l-lysine; l-methionine; l-tryptophan; l-tyrosine; serine; l-cysteine; leucine; l-histidine; proline - solution for infusion - phenylalanine 7.9 g/l; arginine 11.3 g/l; aspartic acid 3.4 g/l; alanine 16 g/l; threonine 5.6 g/l; valine 7.3 g/l; glutamic acid 5.6 g/l; glycine 7.9 g/l; isoleucine 5.6 g/l; l-lysine 9 g/l; l-methionine 5.6 g/l; l-tryptophan 1.9 g/l; l-tyrosine 230 mg/l; serine 4.5 g/l; l-cysteine 560 mg/g; leucine 7.9 g/l; l-histidine 6.8 g/l; proline 6.8 g/l - blood substitutes and perfusion solutions

United States - English - NLM (National Library of Medicine)

viatrexx bio incorporated - 5-hydroxytryptophan 15x 200k, acetylcholinesterase 15x 200k, choline chloride 15x 200k, dopamine 15x 200k, glutamic acid 15x 200k, glycine 15x 200k, histidine 15x 200k, l-dopa 15x 200k, malvin 15x 200k, melanin 15x 200k, melatonin 15x 200k, nitric oxide 15x 200k, norepinephrine 15x 200k, octopamine 15x 200k, o-methyl serotonin 15x 200k, phenylalanine 15x 200k, serotonin 15x 200k, taurine 15x 200k, tryptophan 15x 200k, tyrosine 15x 200k - for the support & balancing of the entire neurological system